40,042 Shares in Ventas, Inc. $VTR Purchased by Dockside LLC

Dockside LLC bought a new position in shares of Ventas, Inc. (NYSE:VTR) during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor bought 40,042 shares of the real estate investment trust’s stock, valued at approximately $3,098,000.

Other large investors also recently bought and sold shares of the company. Deutsche Bank AG increased its holdings in Ventas by 0.7% during the 4th quarter. Deutsche Bank AG now owns 3,904,293 shares of the real estate investment trust’s stock worth $302,114,000 after purchasing an additional 27,688 shares during the period. Vanguard Group Inc. increased its holdings in shares of Ventas by 2.5% in the 3rd quarter. Vanguard Group Inc. now owns 73,598,827 shares of the real estate investment trust’s stock valued at $5,151,182,000 after acquiring an additional 1,802,515 shares during the last quarter. Schroder Investment Management Group increased its holdings in shares of Ventas by 3.6% in the 3rd quarter. Schroder Investment Management Group now owns 2,487,572 shares of the real estate investment trust’s stock valued at $170,946,000 after acquiring an additional 85,340 shares during the last quarter. Aberdeen Group plc boosted its position in shares of Ventas by 8.3% in the 3rd quarter. Aberdeen Group plc now owns 1,580,923 shares of the real estate investment trust’s stock valued at $109,985,000 after purchasing an additional 120,825 shares during the period. Finally, Focus Partners Advisor Solutions LLC boosted its position in shares of Ventas by 182.3% in the 3rd quarter. Focus Partners Advisor Solutions LLC now owns 23,650 shares of the real estate investment trust’s stock valued at $1,782,000 after purchasing an additional 15,273 shares during the period. Hedge funds and other institutional investors own 94.18% of the company’s stock.

Insiders Place Their Bets

In other news, Director Michael J. Embler bought 2,500 shares of Ventas stock in a transaction that occurred on Wednesday, June 3rd. The shares were purchased at an average price of $78.81 per share, for a total transaction of $197,025.00. Following the completion of the acquisition, the director owned 19,202 shares of the company’s stock, valued at $1,513,309.62. The trade was a 14.97% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Walter C. Rakowich sold 1,152 shares of Ventas stock in a transaction on Thursday, May 14th. The shares were sold at an average price of $90.20, for a total value of $103,910.40. Following the completion of the transaction, the director owned 28,349 shares in the company, valued at $2,557,079.80. The trade was a 3.90% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.53% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

A number of analysts recently issued reports on VTR shares. Scotiabank upped their target price on Ventas from $93.00 to $95.00 and gave the company a “sector perform” rating in a research report on Thursday, May 21st. Mizuho set a $98.00 price target on Ventas in a report on Friday, May 22nd. KeyCorp raised their price target on Ventas from $90.00 to $95.00 and gave the company an “overweight” rating in a report on Thursday, May 7th. Weiss Ratings reissued a “buy (b-)” rating on shares of Ventas in a report on Friday, March 27th. Finally, Wells Fargo & Company raised their price target on Ventas from $93.00 to $96.00 and gave the company an “overweight” rating in a report on Monday, June 1st. Fourteen analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to MarketBeat.com, Ventas has an average rating of “Moderate Buy” and a consensus target price of $95.19.

Ventas Price Performance

Shares of Ventas stock opened at $84.58 on Friday. Ventas, Inc. has a twelve month low of $61.76 and a twelve month high of $91.06. The stock has a market capitalization of $41.12 billion, a P/E ratio of 153.79, a PEG ratio of 1.82 and a beta of 0.71. The company has a current ratio of 0.25, a quick ratio of 0.25 and a debt-to-equity ratio of 0.95. The business’s fifty day moving average price is $85.15 and its 200 day moving average price is $82.48.

Ventas (NYSE:VTR) last issued its earnings results on Monday, April 27th. The real estate investment trust reported $0.11 earnings per share for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.01). Ventas had a net margin of 4.25% and a return on equity of 2.09%. The firm had revenue of $1.65 billion during the quarter, compared to analyst estimates of $1.59 billion. During the same quarter in the previous year, the business posted $0.84 EPS. Ventas’s revenue was up 22.0% compared to the same quarter last year. Ventas has set its FY 2026 guidance at 3.820-3.890 EPS. As a group, research analysts anticipate that Ventas, Inc. will post 3.88 earnings per share for the current year.

Ventas Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, July 16th. Investors of record on Tuesday, June 30th will be issued a $0.52 dividend. The ex-dividend date is Tuesday, June 30th. This represents a $2.08 dividend on an annualized basis and a yield of 2.5%. Ventas’s dividend payout ratio (DPR) is presently 378.18%.

About Ventas

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.